BizTrendWire Your quick daily dose of business trends
Your Go-To Hub for Business Trends, Market Insights, and Growth Strategies
Windlas Biotech Limited has approved a share buyback worth up to Rs 47 crore, purchasing 4.7 lakh equity shares from existing investors. The buyback will occur at Rs 1,000 per share, representing 2.23% of the…
Four companies are likely to come up with updates around share buybacks this month. Wipro, Cyient, and Windlas Biotech will consider buyback proposals, while Aurobindo Pharma’s record date for its confirmed buyback is set for…
